Alberto Poli
๐ŸŽ‰๐˜ฝ๐™๐™€๐˜ผ๐™†๐™„๐™‰๐™‚ ๐™‰๐™€๐™’๐™Ž - ๐™‹๐™ค๐™ง๐™ฉ๐™›๐™ค๐™ก๐™ž๐™ค ๐™๐™ฅ๐™™๐™–๐™ฉ๐™š ๐ŸŽ‰ ๐Ÿ“ข ๐™„๐™ฃ๐™ฉ๐™ช๐™ž๐™ฉ๐™ž๐™ซ๐™š ๐™Ž๐™ช๐™ง๐™œ๐™ž๐™˜๐™–๐™ก (๐™„๐™Ž๐™๐™‚): ๐™๐™๐™š ๐™‹๐™š๐™ง๐™›๐™š๐™˜๐™ฉ ๐™Ž๐™ช๐™ง๐™ฅ๐™ง๐™ž๐™จ๐™š! ๐™Œ๐Ÿฏ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐™€๐™–๐™ง๐™ฃ๐™ž๐™ฃ๐™œ๐™จ ๐™Ž๐™š๐™ฃ๐™™ ๐™Ž๐™ฉ๐™ค๐™˜๐™  ๐™Ž๐™ค๐™–๐™ง๐™ž๐™ฃ๐™œ +๐Ÿญ๐Ÿณ% ๐Ÿค– What perfect timing! Intuitive Surgical, the surgical robotics giant, released exceptional results yesterday for the Third Quarter 2025, confirming its solid fundamentals and triggering a stock rally that richly rewarded us. ๐ŸŽฏ ๐™Š๐™ช๐™ง ๐˜ผ๐™ฌ๐™–๐™ง๐™™-๐™’๐™ž๐™ฃ๐™ฃ๐™ž๐™ฃ๐™œ ๐™Ž๐™ฉ๐™ง๐™–๐™ฉ๐™š๐™œ๐™ฎ: ๐™๐™๐™š ๐™๐™š๐™ฉ๐™ช๐™ง๐™ฃ ๐™ฉ๐™ค ๐™„๐™Ž๐™๐™‚ Those who follow me know that ISRG was once a member of our portfolio. Unfortunately, we had closed that position in the past before a period of uncertainty, thereby missing a significant rally. For months, we patiently waited for the right re-entry point, allowing us to acquire shares at more reasonable prices. The company, thanks to its da Vinci system, enjoys an unparalleled competitive advantage and a high-margin recurring revenue model. Just a few days ago, we decided to act. Trusting the company's fundamentals and its da Vinci system, which boasts an undeniable competitive edge and a high-margin recurring revenue model, we began to build our initial long positions. The earnings news, arriving shortly after, was an absolute bombshell! ๐Ÿ“ˆ ๐™๐™๐™š ๐™๐™ง๐™ž๐™ช๐™ข๐™ฅ๐™ ๐™ค๐™› ๐™Œ๐Ÿฏ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ: ๐˜ฝ๐™š๐™ฎ๐™ค๐™ฃ๐™™-๐™€๐™ญ๐™ฅ๐™š๐™˜๐™ฉ๐™–๐™ฉ๐™ž๐™ค๐™ฃ๐™จ ๐˜ฟ๐™–๐™ฉ๐™– Demand for surgical robots is rapidly accelerating, driven by the recovery of the post-pandemic procedure backlog and the expansion of minimally invasive care. The numbers reflect an impressive push from the core business: ๐™€๐™–๐™ง๐™ฃ๐™ž๐™ฃ๐™œ๐™จ ๐˜ฝ๐™š๐™–๐™ฉ: Intuitive Surgical reported an adjusted earnings per share (EPS) of $ 2.40, significantly surpassing analysts' estimates of $ 1.98 per share (LSEG data). Revenue also exceeded expectations, reaching $ 2.51 billion against the $ 2.40 billion forecast. ๐™๐™š๐™˜๐™ค๐™ง๐™™ ๐™‹๐™ง๐™ค๐™˜๐™š๐™™๐™ช๐™ง๐™š ๐™‚๐™ง๐™ค๐™ฌ๐™ฉ๐™: The company raised its forecast for da Vinci-assisted procedure growth for the full year 2025, moving from the previous +15.5% -17% to a more optimistic range of +17% / +17.5%. This is the true indicator of increasing hospital demand. ๐™„๐™ข๐™ฅ๐™ง๐™ค๐™ซ๐™š๐™™ ๐™‚๐™ง๐™ค๐™จ๐™จ ๐™ˆ๐™–๐™ง๐™œ๐™ž๐™ฃ๐™จ: The forecast for adjusted gross profit margins for 2025 was raised to 67% - 67.5%. This improvement is partly due to a reduction in the impact of tariffs and an optimized supply chain. ๐™๐™š๐™˜๐™ช๐™ง๐™ง๐™ž๐™ฃ๐™œ ๐™„๐™ฃ๐™จ๐™ฉ๐™ง๐™ช๐™ข๐™š๐™ฃ๐™ฉ ๐˜ฟ๐™š๐™ข๐™–๐™ฃ๐™™: Consistent growth in procedures ensures substantial revenues from instruments and accessories โ€“ the company's high-margin profit engine. ๐™„๐™ฃ ๐™จ๐™ช๐™ข๐™ข๐™–๐™ง๐™ฎ: Our long-term fundamentals on ISRG were correct. Patience and a strategic waiting game were rewarded by a quarterly announcement that provided the perfect trigger. The initial positions we had built have already delivered an impressive gain in just a few days! $ISRG (Intuitive Surgical Inc) $NSDQ100 $SPX500 $DJ30
null
.